07:00 , Mar 24, 2016 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Reelin (RELN); intercellular adhesion molecule-1 (ICAM-1; CD54); vascular cell adhesion molecule-1 (VCAM-1)

Cardiovascular disease INDICATION: Atherosclerosis Mouse studies suggest inhibiting RELN could help treat atherosclerosis. In a mouse model of atherosclerosis, systemic or liver-specific knockout of RELN decreased plasma levels of total cholesterol, plaque buildup in the...
07:00 , Oct 12, 2015 |  BC Week In Review  |  Company News

University of South Florida, Agilis Biotherapeutics deal

The university granted Agilis exclusive, worldwide rights to develop and commercialize Reelin (RELN) replacement technologies to treat cognitive disorders. Agilis will provide research funding to the university. The university deferred questions Agilis, which declined to...